These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15863215)

  • 1. Late-onset marrow aplasia due to imatinib in newly diagnosed chronic phase chronic myeloid leukaemia.
    Chng WJ; Tan LH
    Leuk Res; 2005 Jun; 29(6):719-20. PubMed ID: 15863215
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone marrow aplasia--a rare complication of imatinib therapy in CML patients.
    Srinivas U; Pillai LS; Kumar R; Pati HP; Saxena R
    Am J Hematol; 2007 Apr; 82(4):314-6. PubMed ID: 17013815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transitory marrow aplasia during Imatinib therapy in a patient with chronic myeloid leukemia.
    Cervetti G; Carulli G; Galimberti S; Azzarà A; Buda G; Orciuolo E; Pelosini M; Petrini M
    Leuk Res; 2008 Jan; 32(1):194-5. PubMed ID: 17459473
    [No Abstract]   [Full Text] [Related]  

  • 4. Late onset aplastic anemia during treatment of chronic myeloid leukemia with imatinib mesylate.
    LeMarbre G; Schinstock C; Hoyer R; Krook J; Tefferi A
    Leuk Res; 2007 Mar; 31(3):414-5. PubMed ID: 17010430
    [No Abstract]   [Full Text] [Related]  

  • 5. Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.
    Khan KA; Junaid A; Siddiqui NS; Mukhtar K; Siddiqui S
    J Coll Physicians Surg Pak; 2008 Mar; 18(3):176-8. PubMed ID: 18460249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gelatinous transformation of the bone marrow as a late morphological change in imatinib mesylate treated chronic myeloid leukaemia.
    Hong FS; Mitchell CA; Zantomio D
    Pathology; 2010 Jan; 42(1):84-5. PubMed ID: 20025487
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term molecular efficacy and safety of imatinib in a patient with chronic myeloid leukaemia after renal transplantation.
    Thierry A; Dreyfus B; Bridoux F; Abou Ayache R; Milin S; Guilhot F; Touchard G
    Nephrol Dial Transplant; 2007 Jun; 22(6):1791-2. PubMed ID: 17308316
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful pregnancies involving men with chronic myeloid leukaemia on imatinib therapy.
    Ramasamy K; Hayden J; Lim Z; Mufti GJ; Ho AY
    Br J Haematol; 2007 May; 137(4):374-5. PubMed ID: 17408403
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustained complete molecular remission after imatinib discontinuation due to severe aplastic anemia.
    Hernández-Boluda JC; Collado M; Roda D; Amat P; Tormo M; Marugán I
    Leuk Res; 2009 Apr; 33(4):589-92. PubMed ID: 18817972
    [No Abstract]   [Full Text] [Related]  

  • 10. STI-571 (Gleevec) in the treatment of chronic myeloid leukaemia.
    Kumar L; Kumari M; Menon H
    Natl Med J India; 2002; 15(5):298. PubMed ID: 12502149
    [No Abstract]   [Full Text] [Related]  

  • 11. Gelatinous transformation of bone marrow in chronic myeloid leukemia during treatment with imatinib mesylate: a disease or a drug effect?
    Ram R; Gafter-Gvili A; Okon E; Pazgal I; Shpilberg O; Raanani P
    Acta Haematol; 2008; 119(2):104-7. PubMed ID: 18367829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate.
    Garipidou V; Vakalopoulou S; Tziomalos K
    Oncologist; 2005; 10(6):457-8. PubMed ID: 15967839
    [No Abstract]   [Full Text] [Related]  

  • 13. Listeria monocytogenes meningitis following imatinib mesylate-induced monocytopenia in a patient with chronic myeloid leukemia.
    Ferrand H; Tamburini J; Mouly S; Bouscary D; Bergmann JF
    Clin Infect Dis; 2005 Dec; 41(11):1684-5. PubMed ID: 16267747
    [No Abstract]   [Full Text] [Related]  

  • 14. Occurrence of colon adenocarcinoma in chronic myeloid leukemia patients treated with imatinib: report of two cases and review of the literature.
    Frustaci A; Breccia M; Cannella L; Stefanizzi C; Alimena G
    Leuk Res; 2009 Jan; 33(1):200-1. PubMed ID: 18452989
    [No Abstract]   [Full Text] [Related]  

  • 15. Pure red cell aplasia in a patient of chronic granulocyte leukemia associated with imatinib.
    Meng HT; Li Y; Jin J; Qian WB; Yang CM
    Ann Hematol; 2007 Mar; 86(3):231-2. PubMed ID: 17123082
    [No Abstract]   [Full Text] [Related]  

  • 16. Cutaneous Lichenoid dermatitis associated with imatinib mesylate.
    Chan CY; Browning J; Smith-Zagone MJ; Martinelli PT; Hsu S
    Dermatol Online J; 2007 May; 13(2):29. PubMed ID: 17498448
    [No Abstract]   [Full Text] [Related]  

  • 17. Hematological and molecular response evaluation of CML patients on imatinib.
    Gupta A; Prasad K
    J Assoc Physicians India; 2007 Feb; 55():109-13. PubMed ID: 17571739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psoriasis vulgaris exacerbated by imatinib therapy in chronic myelogenous leukemia].
    Shimizu K; Kuroda H; Kida M; Watanabe H; Shirao S; Akiyama T; Fujimi A; Tanaka I; Sato T; Matsunaga T; Niitsu Y
    Rinsho Ketsueki; 2005 Oct; 46(10):1152-5. PubMed ID: 16440780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Male patients with chronic myeloid leukemia treated with imatinib involved in healthy pregnancies: report of five cases.
    Breccia M; Cannella L; Montefusco E; Frustaci A; Pacilli M; Alimena G
    Leuk Res; 2008 Mar; 32(3):519-20. PubMed ID: 17804066
    [No Abstract]   [Full Text] [Related]  

  • 20. Imatinib-induced aplastic anemia in a patient with chronic myeloid leukemia.
    Mabed M; Elhefni AM; Damnhouri G
    Leuk Lymphoma; 2012 Nov; 53(11):2310-1. PubMed ID: 22462614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.